MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04755cam a2200529 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
ocn828140642 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20221128212159.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
|---|
| fixed length control field |
m d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr ||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
111020s2012 nyua ob 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2019713466 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| 019 ## - |
|---|
| -- |
923653960 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
9781619422322 |
| Qualifying information |
(ebook) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| ISBN |
1619422328 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
9781619422216 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Cancelled/invalid ISBN |
1619422212 |
| Qualifying information |
(hardcover) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
540894 |
| -- |
(N$T) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)828140642 |
| Canceled/invalid control number |
(OCoLC)923653960 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED |
| Subject category code subdivision |
033000 |
| Source |
bisacsh |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
MAIN |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Cytomegalovirus infections : |
| Subtitle |
risk factors, causes and management |
| Statement of responsibility, etc |
|
| Medium |
[E-Book] |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
Nova Biomedical : |
| -- |
Nova Science Publishers, Inc., |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2012] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Physical description |
1 online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 490 1# - SERIES TITLE |
|---|
| Series statement |
Allergies and Infectious Diseases |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - CONTENTS |
|---|
| Contents |
""CYTOMEGALOVIRUS INFECTIONS ""; ""CYTOMEGALOVIRUS INFECTIONS ""; ""Contents""; ""Preface""; ""Management of Human Cytomegalovirus Infection in Pregnancy""; ""Abstract""; ""1. Introduction""; ""2. Diagnosis of HCMV Infection""; ""2.1. Primary Infection""; ""2.2. Recurrent Infection""; ""3. Maternal Prognostic Markers of In Utero Transmission""; ""4. Invasive Procedures for Prenatal Diagnosis""; ""4.1. Amniocentesis""; ""4.2. Cordocentesis""; ""5. Fetal Prognostic Markers of Congenital Disease""; ""6. Fetal Imaging Techniques""; ""6.1. Ultrasound""; ""6.2. Magnetic Resonance Imaging"" |
| 505 8# - CONTENTS |
|---|
| Contents |
""7. Therapeutic Interventions in Pregnancy""""8. Counseling""; ""Conclusion""; ""Acknowledgments""; ""References""; ""CMV and Male Infertility""; ""Abstract""; ""Introduction""; ""Viruses and Human Semen""; ""Cytomegalovirus (CMV)""; ""Conclusion""; ""References""; ""Cytomegalovirus and the Cognitive Immunity: An Old Married Couple for the Best and the Worst""; ""Abstract""; ""Abbreviations""; ""Introduction""; ""A. Effect of the Immunity on CMV Ecology""; ""B. CMV Infection Effects on the Immune Status""; ""CMV May Influence the Quality of the Immune System"" |
| 505 8# - CONTENTS |
|---|
| Contents |
""Chronic Pro-Inflammatory Effect and Ageing""""CMV Participates in Senescence of the Immune System Itself""; ""CMV Induces the Emergence of Unconventional Phenotypes""; ""CMV Infection and Lymphoproliferative Disorders""; ""Conclusion""; ""References""; ""Human Cytomegalovirus Infection: Risk Factors, Diagnosis, and Impact on Immunity and Health""; ""Abstract""; ""Introduction""; ""Risk Factors for HCMV Infection and Reactivation""; ""Diagnosis""; ""Impact on Immunity and Health""; ""Conclusion""; ""Acknowledgment""; ""References""; ""Immunity to Human Cytomegalovirus""; ""Abstract"" |
| 505 8# - CONTENTS |
|---|
| Contents |
""Introduction""""Immune Response to HCMV Infection""; ""Age-Related HCMV Immunity""; ""HCMV Infection in Immunocompromised Individuals""; ""a) HCMV and Primary Immunodeficiences""; ""b) HCMV in HIV-Positive Individuals""; ""c) HCMV and Transplantation""; ""Immunologic Monitoring for HCMV""; ""References""; ""Antiviral and Vaccine Strategies against Cytomegalovirus: Current Therapies and Future Directions""; ""Abstract""; ""1. Introduction""; ""1.1. CMV Disease""; ""1.2. Virus Structure""; ""2. CMV Antivirals""; ""2.1. CMV Antiviral Ganciclovir and Prodrug"" |
| 505 8# - CONTENTS |
|---|
| Contents |
""2.2. Other Licensed CMV Antivirals""""3. Improving on Current Antivirals and Development of New Antivirals""; ""3.1. Beyond Cidofovir""; ""3.2. Methylenecyclopropane Nucleosides""; ""3.3. Maribavir""; ""3.4. Other UL97 mediated CMV Antivirals""; ""3.5. CMV DNA Terminase Complex and Antivirals""; ""3.6. CMV Antivirals and High Throughput Screening""; ""3.7. RNAi and CMV Antiviral Therapy""; ""3.8. Peptide Based CMV Antivirals""; ""3.9. Thymidine Kinase Antivirals and CMV""; ""3.10. CMV Hyper-Immune Globulin Therapy and Congenital Infection""; ""3.11. CMV and Off Label Drug Therapy"" |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local note |
Master record variable field(s) change: 050, 082 |
| 650 #0 - SUBJECT HEADINGS |
|---|
| Subject term |
Cytomegalovirus infections. |
| 700 1# - ADDED PERSONAL NAME |
|---|
| Added personal author |
Lautenschlager, Irmeli, |
| Relator term |
editor. |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Allergies and infectious diseases. |
| 856 40 - ONLINE RESOURCE |
|---|
| Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=540894">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=540894</a> |
| Link text |
Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Suppress in OPAC |
Do not Suppress in OPAC |
| 938 ## - |
|---|
| -- |
YBP Library Services |
| -- |
YANK |
| -- |
7311370 |
| 938 ## - |
|---|
| -- |
EBSCOhost |
| -- |
EBSC |
| -- |
540894 |
| 938 ## - |
|---|
| -- |
ebrary |
| -- |
EBRY |
| -- |
ebr10654814 |
| 938 ## - |
|---|
| -- |
ProQuest Ebook Central |
| -- |
EBLB |
| -- |
EBL3017843 |
| 994 ## - |
|---|
| -- |
92 |
| -- |
N$T |